Bengaluru: Addressing the curtain-raiser press conference of the 6th edition of Indian Pharma & India Medical Device 2021, Union Chemical and Fertiliser Minister D V Sadananda Gowda said that India's pharmaceutical sector will grow to $130 billion by the year 2030.
Speaking on the occasion, Gowda said that with Prime Minister Narendra Modi taking over the leadership of India, structural reforms have been witnessed by countrymen. Ease of doing business has become possible and India's diplomatic ties and trade policies with other nations have strengthened.
"₹3650 crore foreign investments have been made in the pharmaceutical sector in the year 2019-20. Foreign capital is flowing. Compared to the previous year foreign investment was 98 per cent higher," he added.
Read:|Govt eyes Rs 7.5 lakh crore pharma exports by 2024
Under Atmanirbhar Bharat campaign, many ambitious plans have been adopted to develop the pharmaceutical industry indigenously. Three bulk drug industrial centres are being developed in India and the Centre will provide ₹1,000 crores each to these departments. The main aim is to produce the basic chemicals (APIs & KSMs) needed for drug manufacturing in these industrial centres. The Centre also plans to provide manufacturing-based incentives to make India's pharmaceutical industry competitive. The incentive scheme, which is in effect till 2025, has been earmarked at ₹6940 crores, Sadananda Gowda said.